Abstract
Introduction
Studies have reported higher cancer risk in individuals with psoriasis, a chronic inflammatory autoimmune disease; however, adjustment for potential confounders was lacking.
Methods
We examined the association of psoriasis with cancer incidence in 32,910 women after age 65 in the IWHS cohort linked to Medicare. Psoriasis was defined as: 2+ psoriasis claims from any Medicare file during 1991–2004 or 1+ psoriasis claim from a dermatologist (n = 719). Severe psoriasis was defined as 4+ psoriasis claims from a dermatologist in any year (n = 121). Cox proportional hazards regression, with psoriasis as a time-dependent variable was conducted to calculate hazard ratios (HR) and 95% confidence intervals (CI) of total (n = 6,488), breast (n = 2,066), lung (n = 742), and colon cancers (n = 947).
Results
With age-adjustment, psoriasis (yes vs. no) was associated with increased risk of lung 1.9 (95% CI: 1.2–3.0), colon 1.6 (95% CI: 1.1–2.5), and total cancer 1.2 (95% CI, 1.0–1.4). After further adjustment for smoking, body mass index, education, physical activity, and hormone therapy use, only the association for colon cancer remained statistically significant (HR = 1.6, 95% CI: 1.0–2.4) and was stronger for severe psoriasis.
Conclusion
The observed association between psoriasis and colon cancer may reflect inflammatory or unidentified processes.
Similar content being viewed by others
Notes
E. Warshaw, Department of Dermatology, University of Minnesota, October, 2009, personal communication.
References
Neimann AL, Shin DB, Wang X et al (2006) Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55:829–835
Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of psoriasis. Lancet 370:263–271
Margolis D, Bilker W, Hennessy S et al (2001) The risk of malignancy associated with psoriasis. Arch Dermatol 137:778–783
Weisenseel P, Laumbacher B, Besgen P et al (2002) Streptococcal infection distinguishes different types of psoriasis. J Med Genet 39:767–768
Henseler T, Christophers E (1985) Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13:450–456
Kimball AB, Gladman D, Gelfand JM et al (2008) National psoriasis foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 58:1031–1042
Boffetta P, Gridley G, Lindelof B (2001) Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden. J Invest Dermatol 117:1531–1537
Ji J, Shu X, Sundquist K, Sundquist J et al (2009) Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden. Br J Cancer 100:1499–1502
Brauchli YB, Jick SS, Miret M et al (2009) Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis. J Invest Dermatol 129:2604–2612
Gelfand JM, Shin DB, Neimann AL et al (2006) The risk of lymphoma in patients with psoriasis. J Invest Dermatol 126:2194–2201
Hannuksela-Svahn A, Pukkala E et al (2000) Psoriasis, its treatment, and cancer in a cohort of Finnish patients. J Invest Dermatol 114:587–590
Olsen JH, Frentz G, Moller H (1993) Psoriasis and cancer. Ugeskr Laeger 155:2687–2691
Frentz G, Olsen JH (1999) Malignant tumours and psoriasis: a follow-up study. Br J Dermatol 140:237–242
Lindelof B, Sigurgeirsson B, Tegner E et al (1999) PUVA and cancer risk: the Swedish follow-up study. Br J Dermatol 141:108–112
Paul CF, Ho VC, McGeown C et al (2003) Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. J Invest Dermatol 120:211–216
Stern RS (2006) Lymphoma risk in psoriasis: results of the PUVA follow-up study. Arch Dermatol 142:1132–1135
Folsom AR, Kaye SA, Sellers TA et al (1993) Body fat distribution and 5-year risk of death in older women. JAMA 269:483–487
Folsom AR, Kushi LH, Anderson KE et al (2000) Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women’s Health Study. Arch Intern Med 160:2117–2128
Bisgard KM, Folsom AR, Hong CP et al (1994) Mortality and cancer rates in nonrespondents to a prospective study of older women: 5-year follow-up. Am J Epidemiol 139:990–1000
Virnig B, Durham SB, Folsom AR et al (2004) Linking the Iowa Women’s Health Study cohort to Medicare data: linkage results and application to hip fracture. Am J Epidemiol 172:327–333
Fritz A, Percy C, Jack A (2000) International classification of disease for oncology (ICD-O), 3rd edn. WHO, Geneva
Pearce DJ, Stealey KH, Balkrishnan R et al (2006) Psoriasis treatment in the United States at the end of the 20th century. Int J Dermatol 45:370–374
Folsom AR, Anderson JP, Ross JA (2004) Estrogen replacement therapy and ovarian cancer. Epidemiology 15:100–104
Kleinbaum D, Klein M (2005) Survival analysis: a self-learning text, 2nd edn. Springer, New York
Gelfand JM, Neimann AL, Shin DB et al (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296:1735–1741
Naldi L (2004) Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 3:121–128
Qureshi AA, Choi HK, Setty AR et al (2009) Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol 145:379–382
Setty AR, Curhan G, Choi HK (2007) Smoking and the risk of psoriasis in women: Nurses’ Health Study II. Am J Med 120:953–969
Plunkett A, Marks R (1998) A review of the epidemiology of psoriasis vulgaris in the community. Australas J Dermatol 39:225–232
Gelfand JM, Troxel AB, Lewis JD et al (2007) The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 143:1493–1499
Krueger JG, Bowcock A (2005) Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 64:30–36
Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496–509
Tonel G, Conrad C (2009) Interplay between keratinocytes and immune cells—recent insights into psoriasis pathogenesis. Int J Biochem Cell Biol 41:963–968
Bernatsky S, Ramsey-Goldman R, Clarke A (2006) Malignancy and autoimmunity. Curr Opin Rheumatol 18:129–134
de Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6:24–37
Puntoni M, Marra D, Zanardi S et al (2008) Inflammation and cancer prevention. Ann Oncol 19:225–229
Erlinger TP, Platz EA, Rifai N et al (2004) C-reactive protein and the risk of incident colorectal cancer. JAMA 291:585–590
Il’yasova D, Colbert LH, Harris TB et al (2005) Circulating levels of inflammatory markers and cancer risk in the Health Aging and Body Composition cohort. Cancer Epidemiol Biomarkers Prev 14:2413–2418
Gunter MJ, Stolzenberg-Solomon R, Cross AJ et al (2006) A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res 66:2483–2487
Otani T, Iwasaki M, Sasazuki S et al (2006) Japan Public Health Center-Based Prospective Study Group. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-Based Prospective Study. Cancer Epidemiol Biomarkers Prev 15:690–695
Rhodes JM, Campbell BJ (2002) Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med 8:10–16
Gulliver W (2008) Long-term prognosis in patients with psoriasis. Br J Dermatol 159:2–9
Yates VM, Watkinson G, Kelman A (1982) Further evidence for an association between psoriasis, Crohn’s disease and ulcerative colitis. Br J Dermatol 106:323–330
Katz JN, Barrett J, Liang MH et al (1997) Sensitivity and positive predictive value of Medicare part B physician claims for rheumatologic diagnoses and procedures. Arthritis Rheum 40:1594–1600
Icen M, Crowson CS, McEvoy MT et al (2008) Potential misclassification of patients with psoriasis in electronic databases. J Am Acad Dermatol 59:981–985
Acknowledgments
The authors are thankful to the IWHS staff for consultation and assistance in data preparation. The authors are especially thankful to Bill Baker for help with the analysis of Medicare data. This study was supported by National Cancer Institute grant R01 CA39742.
Conflict of interest
The authors state no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prizment, A.E., Alonso, A., Folsom, A.R. et al. Association between psoriasis and incident cancer: the Iowa’s Women’s Health Study. Cancer Causes Control 22, 1003–1010 (2011). https://doi.org/10.1007/s10552-011-9773-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-011-9773-0